Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Pharma Holdings raises $10 million in financing
Net proceeds from the offering of approximately $9.3 million are expected to be used for expansion of the company’s existing product line, sales and marketing, and general working
Net proceeds from the offering of approximately $9.3 million are expected to be used for expansion of the company’s existing product line, sales and marketing, and general working
Wyeth Research is conducting the Intoract study with the support and assistance of Roche and Genentech. The primary end point of the Intoract study is independently assessed progression-free
Cavit acquired Alternecare’s inventory, customer lists, existing relationships, trademark and website. Cavit has also acquired the consulting services of Ismael Gonzalez, Alternecare’s president. Mr Gonzalez has over 15
According to the company, the enterovirus molecular test quickly and accurately detects the more than 70 known strains of enterovirus, giving physicians the information they need to treat
The target population for the study is adult patients with progressive or recurrent malignant glioma who have failed first-line, standard therapy. Radiolabeled 131Iodine-TM601 is being investigated in multiple
Results showed high complete remission (CR) rates of 19% in the Velcade and dexamethasone (VcD) arm as induction therapy and 35% post-transplantation. These high CR rates contributed to
The trial is being carried out in patients with metastatic or unresectable solid tumors for which known effective measures do not exist or are no longer effective. There
Patients received either two doses of 510mg of intravenous (IV) ferumoxytol within one week or 200mg of oral iron daily for three weeks and were followed for 35
Wellbutrin XL tablets, 150mg, marketed by GlaxoSmithKline, had US sales of approximately $930 million for the 12 months ended March 2008, according to IMS data.
The Austrian Breast & Colorectal Cancer Study Group Trial 12 (ABCSG-12) is an open-label, multicenter, Phase III study that enrolled 1,803 premenopausal women with oestrogen-receptor-positive Stage I or